YungShin Global Holding Corporation (3705.TW)

TWD 54.0

(0.75%)

Market Cap (In TWD)

14.38 Billion

Revenue (In TWD)

7.02 Billion

Net Income (In TWD)

827.3 Million

Avg. Volume

594.22 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
45.8-63.3
PE
-
EPS
-
Beta Value
0.065
ISIN
TW0003705000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Chih-Wei Chien
Employee Count
-
Website
https://www.yungshingroup.com
Ipo Date
2000-01-04
Details
YungShin Global Holding Corporation, through its subsidiaries, engages in the investment, manufacture, and sale of medicines, animal drugs, agricultural chemicals, industrial medicine, and cosmetics in Taiwan, Mainland China, Japan, and the United States. The company engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, authorization, and outsourcing of services, as well as import and export trading. In addition, it is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment. The company was founded in 1952 and is based in Taichung, Taiwan.